← Eichor
Condition: Factor Viii Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Factor Viii

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Pr
Phase 4 · 2 location(s) · Sanofi · NCT06145373Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A P
Phase N/A · 59 location(s) · Octapharma · NCT03695978A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Phase 3 · 2 location(s) · Hoffmann-La Roche · NCT07416526Gene Therapy for Chinese Hemophilia A
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04728841Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
Phase N/A · 1 location(s) · Karolinska Institutet · NCT02453542World Bleeding Disorders Registry
Phase N/A · 1 location(s) · World Federation of Hemophilia · NCT03327779ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05888870Monitoring of Anti-TFPI in Hemophilia
Phase N/A · 2 location(s) · Hospices Civils de Lyon · NCT07101926Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Effects of Photobiomodulation in Hemophilia Patients.
NA · 1 location(s) · Riphah International University · NCT07579585Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Phase 4 · 18 location(s) · Octapharma · NCT05935358Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B R
Phase 3 · 23 location(s) · Pfizer · NCT05568719Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry
Phase N/A · 2 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06992076Liver Biopsy In Haemophilia Gene Therapy
NA · 1 location(s) · University College, London · NCT04817462Manual Therapy in Hemophilic Arthropathy of the Ankle
NA · 1 location(s) · Investigación en Hemofilia y Fisioterapia · NCT06816056The CACHE Study: Coronary Artery Care in HaEmophilia
Phase N/A · 1 location(s) · Oxford University Hospitals NHS Trust · NCT06706206Embolization in Hereditary Coagulopathies
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT05629130A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Phase 1 · 33 location(s) · Novo Nordisk A/S · NCT07220564A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Hea
Phase 1 · 10 location(s) · Equilibra Bioscience LLC · NCT06349473SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Phase 3 · 2 location(s) · Emory University · NCT04563520To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A
Phase 3 · 13 location(s) · Gritgen Therapeutics Co., Ltd. · NCT06833983Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Phase N/A · 5 location(s) · Peking University People's Hospital · NCT06727669High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Phase N/A · 1 location(s) · Yigeng Cao,MD,PhD · NCT07205523A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Phase 1/Phase 2 · 2 location(s) · Hoffmann-La Roche · NCT07226206A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Year
Phase 3 · 30 location(s) · Sanofi · NCT07285460Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys
Phase 4 · 1 location(s) · Runhui WU · NCT06864975Long-term Anticoagulation in a Patient With Severe Hemophilia A
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07314983The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Phase N/A · 39 location(s) · PedNet Haemophilia Research Foundation · NCT02979119A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan
Phase N/A · 10 location(s) · Sanofi · NCT06684314A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
Phase N/A · 1 location(s) · Takeda · NCT06461533
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.